Ocata Therapeutics Inc fka OCAT

[rocky301]

Responses to a few questions,

When is the 10Q due date?
Due: Monday, May 10, 2010

Remember, we are now an accelerated filer. Instead of 45 days to file 10Q, we now have 40 days. Instead of 90 days to file 10K, we now have 75 days. You can use the "Filing Deadline Calculator" found here:
http://www.secfile.net/SEC_calendar.htm#Filing_deadline_calculator

In the last Corporate presentation the following were listed, do you know what the 2nd cellular-based program might be?
File 2nd Phase I IND for another Retinal Disease 2nd half 2010
Announce 2nd cellular-based IND in area other than retinal program
2nd half 2010

Based on the following statement from January I am assuming it will be in the Vascular area which is the hemangioblast program which is with our JV partner-CHA (SCRMI).

"In addition, ACT has an hemangioblast cell program in preclinical research for possible use of the cells to treat cardiovascular disease, stroke and cancer. ACT's research, published in Nature Methods, has demonstrated success in treating vascular indications such as heart attack and limb loss due to vascular damage. An IND for that program is expected to be filed in 2010."
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=45319759